Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Neurodegeneration Stories

Pesticide Banned In The USA Linked To Alzheimer's Disease
2014-01-29 07:46:56

Rebekah Eliason for redOrbit.com – Your Universe Online For over 40 years scientists have recognized that DDT, a synthetic pesticide, harms bird habitats and is a threat to the environment. Although DDT was banned in the United States in 1972, other countries continue to use it as a pesticide. According to a new study from Rutgers University, exposure to DDT may cause increased risk and severity of Alzheimer’s disease. This is particularly true for people over 60 years of age. As...

2014-01-24 11:40:44

Using a novel high-throughput screening process, scientists have for the first time identified molecules with the potential to block the accumulation of a toxic eye protein that can lead to early onset of glaucoma. Glaucoma is a group of diseases that can damage the eye’s optic nerve and cause vision loss and blindness. Elevated eye pressure is the main risk factor for optic nerve damage. Researchers have implicated a mutant form of a protein called myocilin as a possible root cause...

2014-01-08 17:05:18

Gladstone findings challenge conventional wisdom; point to new therapeutic strategies The most devastating aspect of Parkinson's disease may not be its debilitating symptoms, which rob its victims of their ability to control their own movement. It may not be the millions around the world and their families who suffer each day from the disease's harmful effects. Instead, it may in fact be that its root causes remain largely a mystery. But now, scientists at the Gladstone Institutes have...

Alzheimer’s Disease Tracked From The Beginning
2013-12-23 04:42:10

redOrbit Staff & Wire Reports - Your Universe Online By combining high-resolution functional MRI (fMRI) imaging scans in Alzheimer’s disease patients with mouse models of the neurodegenerative condition, researchers from Columbia University Medical Center (CUMC) have gained new insights into how, where and why the disease starts and spreads. The study, which was published Sunday in the online edition of Nature Neuroscience, will help enhance the medical community’s understanding...

2013-12-19 08:28:23

- Novel Approach to Target Disease-driving Misfolded Proteins - CAMBRIDGE, Mass., Dec. 19, 2013 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc. today announced that it has been awarded an $822,000 grant by The Michael J. Fox Foundation for Parkinson's Research (MJFF) for its second-generation drug candidate, NPT088, based on NeuroPhage's GAIM (general amyloid interaction motif) platform, which simultaneously targets multiple misfolded proteins central to many neurodegenerative...

2013-12-18 15:08:14

Research team identified Neurexin2 as a novel target for potential therapy of neurodegeneration in Spinal Muscular Atrophy patients A recent study led by scientists from the National University of Singapore (NUS) opens a possible new route for treatment of Spinal Muscular Atrophy (SMA), a devastating disease that is the most common genetic cause of infant death and also affects young adults. As there is currently no known cure for SMA, the new discovery gives a strong boost to the fight...

Alzheimer Amyloid Protein New Nanomaterial
2013-12-16 13:26:31

Lee Rannals for redOrbit.com - Your Universe Online The amyloid protein, known for causing diseases like Alzheimer’s and Parkinson’s, may be the next big nanomaterial. Researchers at Chalmers University of Technology found the amyloid protein could lead to the development of new composite materials for nano processors and data storage units of tomorrow, and could potentially even help create invisibility technology. “This finding will provide the opportunity to develop nonlinear...

2013-12-03 23:02:00

St. Jude Children’s Research Hospital scientists identify enzyme that could lead to better diagnosis and treatment of Alzheimer’s disease and related disorders. Memphis, Tenn. (PRWEB) December 03, 2013 St. Jude Children’s Research Hospital scientists have identified an enzyme that can halt or possibly even reverse the build-up of toxic protein fragments known as plaques in the brains of mice with Alzheimer’s disease. The research appeared in a recent edition of the scientific...

2013-12-03 08:34:23

--Inaugural Effort to Unite World Dignitaries, Scientific Leaders and Finance Executives in Fight Against Dementia-- CAMBRIDGE, Mass., Dec. 3, 2013 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc. today announced that it has been invited to participate in the world's first G8 Dementia Summit. The G8 Summit is hosted by the British Prime Minister, David Cameron, and Health Secretary, Jeremy Hunt, and will be attended by G8 Health Ministers, pharmaceutical company leaders,...

2013-11-27 13:19:32

A new study published 26th November in the open access journal PLOS Biology, identifies a new target in the search for therapeutic interventions for Huntington's disease – a devastating late-onset neurodegenerative disorder. The disease is genetic, affecting up to one person in 10,000, and from the age of about 35 leads to increasingly severe problems with movement, mental function, and behavior. Patients usually die within 20 years of onset, and there is to date no treatment that will...